Learn More
Medchemexpress LLC SARS-CoV-2-IN-86 | 368866-07-3 | MFCD02683117 | 99.4% | 466.53 | C26H30N2O6 | 1 G

Supplier: Medchemexpress LLC HYW0244851G
SARS-CoV-2-IN-86 is a small-molecule research compound that inhibits SARS-CoV-2 methyltransferases (nsp14 and nsp16) and is reported as an andrographolide derivative. It is supplied as a solid or as a 10 mM solution in DMSO for in vitro antiviral and enzymatic studies. Batch-specific certificates of analysis and safety documentation are available from the supplier.
- Inhibits SARS-CoV-2 methyltransferases (nsp14 and nsp16).
- Andrographolide derivative for antiviral research.
- Available as solid and 10 mM solution in DMSO.
- High purity (≈99.4%) per supplier documentation.
- Suitable for in vitro enzymatic and antiviral assays.
- Powder stable at -20°C; solvent storage guidelines available.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.